ArticleGastrointestinal cancer research : GCR2012

A phase 2 trial of ixabepilone plus cetuximab in first-line treatment of metastatic pancreatic cancer.

Caio M Rocha Lima et al.PubMed ↗Full text ↗

No numbers read from the abstract.